Lynn D. Cornell, M.D.

Renal Pathologist; Professor of Pathology and Laboratory Medicine, University of Calgary #renalpath

[American Journal of Transplantation @amjtransplant]

🔓 Open Access
"The Banff 2024 Kidney Meeting Report: Rejection as a spectrum of phenotypes and focus on differential diagnostic reasoning," Naesens et al.
https://t.co/YJ4ezXiB6V
#Transplantation #KidneyTransplant #Banff #TransplantPathology #DifferentialDiagnosis #OpenAccess

[Lynn D. Cornell, M.D. @ldcornell]

@BradenMannsYYC 👏 👏 👏

[Swapnil Hiremath @hswapnil.medsky.social @hswapnil]

Comprehensive review on the spectrum of tubulointerstitial disease from @ldcornell

https://t.co/NmLEWyEVZ3 in Kidney International @Kidney_Int

[Lynn D. Cornell, M.D. @ldcornell]

@MPerazella @hswapnil @JohannMorelle @Kidney_Int Thank you both!

[Lynn D. Cornell, M.D. @ldcornell]

@grace_choung @set_fortess @MayoClinic 👏

[Lynn D. Cornell, M.D. @ldcornell]

@grace_choung Taxonomy before ontology, a time-honoured tradition. I haven’t seen convincing evidence that “PIG” is a separate entity from membranous GN.

[Renal Pathology Society @Renalpathsoc]

The Cornell Travel Grant
With generous support from @ldcornell, RPS is pleased to offer 2 travel grants for the 2026 Banff Conference.
Applicants should be RPS members; non-members may apply for membership when submitting:
https://t.co/Sd4gUveJlC
#renalpath

[Lynn D. Cornell, M.D. @ldcornell]

@SaynaNorouzi Sorry to miss the poster in person. Given the prior steroid exposure, I wouldn’t call this true “monotherapy”. This case would support initial steroids to suppress inflammation in the setting of very “active” disease, followed by anti-B cell therapy for long term management.

[Lynn D. Cornell, M.D. @ldcornell]

@sam_albadri @Renalpathsoc @MayoClinicPath @MayoClinicNeph Love this! Well said Sam.

[Lynn D. Cornell, M.D. @ldcornell]

The Banff 2024 meeting report is official! Link to the article (free access) is below- now get ready for the next Banff meeting, October 5-9, 2026, in beautiful Banff, Alberta, Canada!!
https://t.co/C0CkJ27vB3 @Renalpathsoc #renalpath

[Lynn D. Cornell, M.D. @ldcornell]

@sam_albadri @MayoClinicPath @MayoClinicNeph @Renalpathsoc Congratulations!!! 🥳

[Lynn D. Cornell, M.D. @ldcornell]

@JZRenalPath @sam_albadri @Renalpathsoc The Banff scores are diagnosis-agnostic. I think the A/C indices (at least initially) should just apply to rejection… in the Banff post meeting survey, only 66% said that we should consider reporting these indices on all cases.

[Jonathan Zuckerman MD PhD @JZRenalPath]

Nice example of pigmented nephropathy (likely myoglobin cast nephropathy) in an autopsy case (sepsis). I find this is a frequently overlooked finding in autopsy cases. Trichrome highlights the casts bright red. Can also do myoglobin stain to confirm. #renalpath #autopsypath

[Lynn D. Cornell, M.D. @ldcornell]

@shary_tang @JZRenalPath https://t.co/Xj1vnlwgRu is this the lesion you’re referring to? Mark Haas had a nice paper on it!

[Lynn D. Cornell, M.D. @ldcornell]

Why is IgG4-related kidney disease overlooked or misdiagnosed? #renalpath @Renalpathsoc @VuMedi @IgG4ward #IgG4
https://t.co/ANhJsSBPaP

[Leonardo V. Riella @LVRiella]

Not all glomerular disease is the same. Yet many kidney transplant trials still exclude these patients altogether. Fresh off the press! https://t.co/varuZfFweh

[Jonathan Zuckerman MD PhD @JZRenalPath]

Reminder to review non-neoplastic tissue in tumor nephrectomies. #renalpath always takes a quick look here. Slightly tedious but can be very useful. RCC pt with amyloidosis. Amyloid A IHC positive (can be seen with RCC); mass spec pending. #nephrology #pathwitter #nephrology

[U Calgary @UCalgary]

UCalgary claims top five spot in national research rankings. How does this impact you and your community? https://t.co/rNA47319kB

[Renal Pathology Society @Renalpathsoc]

RPS and Banff Activity/Chronicity Working Group
WITH REGISTRATION LINK
https://t.co/rD5pFsglyT